Researchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
COVID-19 vaccination in RMD patients: Safety data “reassuring”March 29, 2021COVID-19 UpdatesAnkylosing spondylitisGoutLupus & Connective Tissue DiseasesOrthopedicsOsteoarthritisOsteoporosis
FDA warning letters target OTC cannabidiol product claims for pain reliefMarch 25, 2021PainOsteoarthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Checkpoint inhibitor–induced rheumatic complications often arise lateMarch 15, 2021Rheumatoid ArthritisLupus & Connective Tissue DiseasesSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
To improve psoriatic arthritis outcomes, address common comorbiditiesMarch 12, 2021Psoriatic Arthritis
Recent psoriasis pathophysiology insights carry treatment implicationsMarch 4, 2021Psoriatic Arthritis
Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patientsFebruary 25, 2021Psoriatic ArthritisRheumatoid Arthritis
COVID-19 vaccination recommended for rheumatology patientsFebruary 24, 2021COVID-19 UpdatesAnkylosing spondylitisGoutLupus & Connective Tissue DiseasesOsteoarthritisOsteoporosisPediatrics
Pandemic puts patients with psoriatic disease off seeking medical helpFebruary 23, 2021Psoriatic ArthritisCOVID-19 Updates
Anybody for a nanobody? Novel psoriasis therapy impresses in phase 2bFebruary 10, 2021Psoriatic Arthritis
Rheumatologic disease activity an important influencer of COVID-19 death riskFebruary 5, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesGoutAnkylosing spondylitis
FDA alert confirms heart and cancer risks with tofacitinib (Xeljanz)February 5, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatrics
